| Dr Venkateswara Roa Atluru, MD | |
|
5645 Main St, Flushing, NY 11355-5045 | |
| (718) 670-1435 | |
| Not Available |
| Full Name | Dr Venkateswara Roa Atluru |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 51 Years |
| Location | 5645 Main St, Flushing, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164456810 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 138208-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York-presbyterian/queens | Flushing, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Valley Anesthesiology Pa | 0749194868 | 163 |
News Archive
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, submitted written comments on March 20 to the U.S. Food and Drug Administration (FDA) in response to the agency's request for feedback in association with its February 20, 2015 public workshop entitled, "Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests."
The molecular roots of inflammatory and autoimmune diseases such as asthma, arthritis, and multiple sclerosis (MS) have been discovered by a team of researchers led by The University of Texas M. D. Anderson Cancer Center. They say their findings may point to ways to effectively treat these diseases - if not stop them before they start.
Reductions to public health and nonemergency services by state and county health departments in response to the economic recession have resulted in limited access to care for undocumented immigrants, the Christian Science Monitor reports.
A group of Canadian researchers led by Prof. Jean-Pierre Pelletier, Head of the Osteoarthritis Research Unit at the University of Montreal Hospital Research Centre, published a clinical trial in which they confirm, for the first time using quantitative Magnetic Resonance Imaging, the disease modifying effects of chondroitin sulphate, a symptomatic slow acting drug for osteoarthritis.
Boston Scientific Corporation releases its schedule of product-related clinical research at the 61th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 24-27 in Chicago.
› Verified 2 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851456701 PECOS PAC ID: 1355232422 Enrollment ID: O20040329001569 |
News Archive
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, submitted written comments on March 20 to the U.S. Food and Drug Administration (FDA) in response to the agency's request for feedback in association with its February 20, 2015 public workshop entitled, "Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests."
The molecular roots of inflammatory and autoimmune diseases such as asthma, arthritis, and multiple sclerosis (MS) have been discovered by a team of researchers led by The University of Texas M. D. Anderson Cancer Center. They say their findings may point to ways to effectively treat these diseases - if not stop them before they start.
Reductions to public health and nonemergency services by state and county health departments in response to the economic recession have resulted in limited access to care for undocumented immigrants, the Christian Science Monitor reports.
A group of Canadian researchers led by Prof. Jean-Pierre Pelletier, Head of the Osteoarthritis Research Unit at the University of Montreal Hospital Research Centre, published a clinical trial in which they confirm, for the first time using quantitative Magnetic Resonance Imaging, the disease modifying effects of chondroitin sulphate, a symptomatic slow acting drug for osteoarthritis.
Boston Scientific Corporation releases its schedule of product-related clinical research at the 61th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 24-27 in Chicago.
› Verified 2 days ago
| Entity Name | Queens Physician Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740222926 PECOS PAC ID: 8325024862 Enrollment ID: O20040625000841 |
News Archive
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, submitted written comments on March 20 to the U.S. Food and Drug Administration (FDA) in response to the agency's request for feedback in association with its February 20, 2015 public workshop entitled, "Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests."
The molecular roots of inflammatory and autoimmune diseases such as asthma, arthritis, and multiple sclerosis (MS) have been discovered by a team of researchers led by The University of Texas M. D. Anderson Cancer Center. They say their findings may point to ways to effectively treat these diseases - if not stop them before they start.
Reductions to public health and nonemergency services by state and county health departments in response to the economic recession have resulted in limited access to care for undocumented immigrants, the Christian Science Monitor reports.
A group of Canadian researchers led by Prof. Jean-Pierre Pelletier, Head of the Osteoarthritis Research Unit at the University of Montreal Hospital Research Centre, published a clinical trial in which they confirm, for the first time using quantitative Magnetic Resonance Imaging, the disease modifying effects of chondroitin sulphate, a symptomatic slow acting drug for osteoarthritis.
Boston Scientific Corporation releases its schedule of product-related clinical research at the 61th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 24-27 in Chicago.
› Verified 2 days ago
| Entity Name | Northern Valley Anesthesiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245289487 PECOS PAC ID: 0749194868 Enrollment ID: O20151023001503 |
News Archive
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, submitted written comments on March 20 to the U.S. Food and Drug Administration (FDA) in response to the agency's request for feedback in association with its February 20, 2015 public workshop entitled, "Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests."
The molecular roots of inflammatory and autoimmune diseases such as asthma, arthritis, and multiple sclerosis (MS) have been discovered by a team of researchers led by The University of Texas M. D. Anderson Cancer Center. They say their findings may point to ways to effectively treat these diseases - if not stop them before they start.
Reductions to public health and nonemergency services by state and county health departments in response to the economic recession have resulted in limited access to care for undocumented immigrants, the Christian Science Monitor reports.
A group of Canadian researchers led by Prof. Jean-Pierre Pelletier, Head of the Osteoarthritis Research Unit at the University of Montreal Hospital Research Centre, published a clinical trial in which they confirm, for the first time using quantitative Magnetic Resonance Imaging, the disease modifying effects of chondroitin sulphate, a symptomatic slow acting drug for osteoarthritis.
Boston Scientific Corporation releases its schedule of product-related clinical research at the 61th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 24-27 in Chicago.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Venkateswara Roa Atluru, MD Po Box 30548, New York, NY 10087-0548 Ph: (517) 787-6440 | Dr Venkateswara Roa Atluru, MD 5645 Main St, Flushing, NY 11355-5045 Ph: (718) 670-1435 |
News Archive
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, submitted written comments on March 20 to the U.S. Food and Drug Administration (FDA) in response to the agency's request for feedback in association with its February 20, 2015 public workshop entitled, "Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests."
The molecular roots of inflammatory and autoimmune diseases such as asthma, arthritis, and multiple sclerosis (MS) have been discovered by a team of researchers led by The University of Texas M. D. Anderson Cancer Center. They say their findings may point to ways to effectively treat these diseases - if not stop them before they start.
Reductions to public health and nonemergency services by state and county health departments in response to the economic recession have resulted in limited access to care for undocumented immigrants, the Christian Science Monitor reports.
A group of Canadian researchers led by Prof. Jean-Pierre Pelletier, Head of the Osteoarthritis Research Unit at the University of Montreal Hospital Research Centre, published a clinical trial in which they confirm, for the first time using quantitative Magnetic Resonance Imaging, the disease modifying effects of chondroitin sulphate, a symptomatic slow acting drug for osteoarthritis.
Boston Scientific Corporation releases its schedule of product-related clinical research at the 61th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 24-27 in Chicago.
› Verified 2 days ago
Dr. Oscar Roldan, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 14030 Beech Ave Apt 4t, Flushing, NY 11355 Phone: 407-506-6751 | |
Deemah Stalhamer, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4500 Parsons Blvd, Flushing, NY 11355 Phone: 718-670-5631 Fax: 718-670-4446 | |
Adam Hom, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 10201 66th Rd, Flushing, NY 11375 Phone: 917-837-2030 | |
William E Perez, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4500 Parsons Blvd, Flushing, NY 11355 Phone: 718-670-5631 Fax: 718-670-4446 | |
Michelle Evans, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4500 Parsons Blvd, Flushing, NY 11355 Phone: 718-670-5631 Fax: 718-670-4446 | |
Dr. Usha Krishnamurthy, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5516 Main St, Suite 1b, Flushing, NY 11355 Phone: 718-461-0017 Fax: 718-461-0018 | |
Rafaelita B Samala, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3609 Main St, Suite 201, Flushing, NY 11354 Phone: 718-321-7558 |